2024 Q1 Form 10-K Financial Statement

#000164033424000460 Filed on March 22, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $16.90K $8.550K
YoY Change 35.2% -3.93%
% of Gross Profit
Research & Development $0.00 $0.00
YoY Change -100.0% -100.0%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $16.90K $8.550K $41.15K
YoY Change 35.2% -68.8% -37.03%
Operating Profit
YoY Change
Interest Expense $9.042K -$9.140K $36.27K
YoY Change 1.11% 0.0% -3.66%
% of Operating Profit
Other Income/Expense, Net -$9.042K -$36.27K
YoY Change 1.11% -3.66%
Pretax Income -$25.94K -$17.69K
YoY Change 20.99% -51.59%
Income Tax
% Of Pretax Income
Net Earnings -$25.94K -$17.69K -$77.42K
YoY Change 20.98% -51.59% -24.83%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 27.82M shares 27.82M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $0.00 $0.00
Short-Term Investments
Other Short-Term Assets $0.00 $0.00 $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $0.00 $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00 $0.00 $0.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $0.00 $0.00 $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $58.21K $57.76K $57.76K
YoY Change 5.41% -3.18% -3.18%
Accrued Expenses $109.7K $106.1K $217.3K
YoY Change 15.25% 15.8% 20.03%
Deferred Revenue
YoY Change
Short-Term Debt $156.3K $0.00 $0.00
YoY Change 37.43% -100.0% -100.0%
Long-Term Debt Due $155.6K $155.6K $155.6K
YoY Change 0.0% 0.0% 0.0%
Total Short-Term Liabilities $596.5K $570.5K $570.5K
YoY Change 15.92% 15.7% 15.7%
LONG-TERM LIABILITIES
Long-Term Debt $67.33K $67.33K $67.33K
YoY Change 0.0% 0.0% 0.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $67.33K $67.33K $67.33K
YoY Change 0.0% 0.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $596.5K $570.5K $570.5K
Total Long-Term Liabilities $67.33K $67.33K $67.33K
Total Liabilities $663.8K $637.9K $637.9K
YoY Change 14.08% 13.81% 13.81%
SHAREHOLDERS EQUITY
Retained Earnings -$233.4M -$233.4M
YoY Change 0.04% 0.03%
Common Stock $237.9M $237.9M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$663.8K -$637.9K -$637.9K
YoY Change
Total Liabilities & Shareholders Equity $0.00 $0.00 $0.00
YoY Change

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$25.94K -$17.69K -$77.42K
YoY Change 20.98% -51.59% -24.83%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$16.45K -$26.11K -$43.05K
YoY Change -2.89% 7.23% -30.34%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $16.45K 26.11K $43.05K
YoY Change -2.89% 7.23% -30.34%
NET CHANGE
Cash From Operating Activities -$16.45K -26.11K -$43.05K
Cash From Investing Activities
Cash From Financing Activities $16.45K 26.11K $43.05K
Net Change In Cash $0.00 0.000 $0.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$16.45K -$26.11K -$43.05K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2160 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
67326 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
67326 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-102996 usd
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001619227
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27819385 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27819385 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27819385 shares
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
333-199193
CY2023 dei Entity Registrant Name
EntityRegistrantName
Cloudweb, Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-0978297
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
800 W El Camino Real Suite 180
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Mountain View
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94040
CY2023 dei City Area Code
CityAreaCode
773
CY2023 dei Local Phone Number
LocalPhoneNumber
236-8132
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
2518829 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27819385 shares
CY2023 dei Auditor Name
AuditorName
BF Borgers CPA PC
CY2023 dei Auditor Firm
AuditorFirmId
5041
CY2023 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2160 usd
CY2023Q4 clow Due To Related Party Current
DueToRelatedPartyCurrent
139809 usd
CY2022Q4 clow Due To Related Party Current
DueToRelatedPartyCurrent
96760 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27819385 shares
CY2023 us-gaap Professional Fees
ProfessionalFees
41150 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
46849 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18500 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
41150 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
65349 usd
CY2023 us-gaap Interest Expense
InterestExpense
36268 usd
CY2022 us-gaap Interest Expense
InterestExpense
37647 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-36268 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-37647 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-77418 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-102996 usd
CY2023 clow Earnings Per Common Share Basic And Diluted
EarningsPerCommonShareBasicAndDiluted
-0.00
CY2022 clow Earnings Per Common Share Basic And Diluted
EarningsPerCommonShareBasicAndDiluted
-0.00
CY2023 clow Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
27819385 shares
CY2022 clow Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
25930649 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-459946 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2022 clow Share Issuance For Repayment Of Convertible Note Amount
ShareIssuanceForRepaymentOfConvertibleNoteAmount
2500 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-102996 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-560442 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-77418 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-637860 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-77418 usd
CY2023 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1184 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1899 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3547 usd
CY2023 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
36268 usd
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
36465 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-43049 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-61800 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
43049 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
61800 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
43049 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
61800 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023 clow Share Issuance For Director Compensation
ShareIssuanceForDirectorCompensation
0 usd
CY2022 clow Share Issuance For Director Compensation
ShareIssuanceForDirectorCompensation
104250000 usd
CY2023 clow Repayments Of Convertible Debt Share Issued
RepaymentsOfConvertibleDebtShareIssued
0 usd
CY2022 clow Repayments Of Convertible Debt Share Issued
RepaymentsOfConvertibleDebtShareIssued
2500 usd
CY2023 us-gaap Nature Of Operations
NatureOfOperations
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 1 – ORGANIZATION AND BUSINESS OPERATIONS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cloudweb, Inc. (the “Company”, or “we”) is a Florida corporation incorporated on May 25, 2014 as Formigli, Inc. In December 2015, the Company changed its name to Data Backup, Inc., and on November 4, 2016, the Company changed its name to Data Backup Solutions Inc. On October 1, 2017, the Company changed its name to Cloudweb, Inc.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We are currently exploring different options of further developing and marketing our web hosting and data storage services. This includes plans to make hosting available for free while being supported by advertiser content. The Company will also look into white labeling its services to allow other brands to use our platforms for their own needs.</p>
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
67326 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
67326 usd
CY2023Q4 clow Debt Instrument Accrued Interest
DebtInstrumentAccruedInterest
111256 usd
CY2022Q4 clow Debt Instrument Accrued Interest
DebtInstrumentAccruedInterest
89464 usd
CY2023 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
55327097 shares
CY2022 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
57826667 shares
CY2023Q4 clow Due To Related Party Current
DueToRelatedPartyCurrent
139809 usd
CY2022Q4 clow Due To Related Party Current
DueToRelatedPartyCurrent
96760 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
69486 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
69486 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2160 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2160 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
0 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1184 usd
CY2023Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
153482 usd
CY2022Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
154798 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
153482 usd
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
CY2022Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
153482 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
106070 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
95164 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
780070 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
702652 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
163815 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
147557 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
163815 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
147557 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
780000 usd
CY2023Q4 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.50 pure

Files In Submission

Name View Source Status
0001640334-24-000460-index-headers.html Edgar Link pending
0001640334-24-000460-index.html Edgar Link pending
0001640334-24-000460.txt Edgar Link pending
0001640334-24-000460-xbrl.zip Edgar Link pending
clow-20231231.xsd Edgar Link pending
clow_10k.htm Edgar Link pending
clow_ex311.htm Edgar Link pending
clow_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
clow-20231231_def.xml Edgar Link unprocessable
clow-20231231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
clow_10k_htm.xml Edgar Link completed
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
clow-20231231_cal.xml Edgar Link unprocessable
clow-20231231_lab.xml Edgar Link unprocessable